AI Doctors Allowed to Reissue Prescriptions in Utah, Sparking Medical Industry Backlash

Concerns are mounting within the medical community following the launch of a pilot program in Utah that allows artificial intelligence (AI) technology to reissue prescription drugs. Utah is pursuing this initiative through AI startup 'Doximity' to tackle its chronic physician shortage and enhance patients' access to medications.

The Utah Medical Association has signed a letter demanding the program's suspension, citing issues with the safety and accountability of AI-generated prescriptions. The debate over AI in medicine is spreading beyond Utah nationwide. States are showing contrasting approaches, with New York advancing legislation to ban AI chatbots from practicing medicine, while Iowa and Idaho have proposed bills to grant clinical licenses for AI medical services.

According to data released by the Utah state government, 91% of AI-renewed prescriptions were approved by human physicians, with only about 3% being denied. Jack Boyd, Utah's Director of Artificial Intelligence Policy, stated that the pilot program was designed conservatively and required malpractice insurance. He added that there have been no safety incidents warranting significant concern to date.